Possibilities of using beta-blockers in the therapy of portal hypertension in dogs caused by liver cirrhosis

被引:0
|
作者
Glinska, K [1 ]
Nicpon, J [1 ]
Wrzosek, M [1 ]
Kungl, K [1 ]
机构
[1] AR, Wydzial Med Weterynaryjnej, Katedra Chorob Wewnetrznych & Pasozytniczych, Klin Chorob Koni Psow & Kotow, PL-50366 Wroclaw, Poland
关键词
portal hypertension; liver cirrhosis; dog;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Liver cirrhosis is a disease common in veterinary gastroenterology. Advanced liver cirrhosis leads to hemodynamic disorders and the onset of portal hypertension. The article presents the possibilities of using non-selective adrenolitics that inhibit both beta I and beta 2 adrenergic receptors (propranolol) in the treatment of portal hypertension in dogs with liver cirrhosis.
引用
收藏
页码:739 / 741
页数:3
相关论文
共 50 条
  • [1] Beta-blockers in liver cirrhosis
    Giannelli, Valerio
    Lattanzi, Barbara
    Thalheimer, Ulrich
    Merli, Manuela
    ANNALS OF GASTROENTEROLOGY, 2014, 27 (01): : 20 - 26
  • [2] Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis
    Danielsen, Karen Vagner
    Hove, Jens Dahlgaard
    Nabilou, Puria
    Yin, Meng
    Chen, Jun
    Zhao, Mirabella
    Kallemose, Thomas
    Teisner, Ane Sogaard
    Siebner, Hartwig Roman
    Ehman, Richard L.
    Moller, Soren
    Bendtsen, Flemming
    LIVER INTERNATIONAL, 2021, 41 (09) : 2149 - 2158
  • [3] The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension, and Ascites
    Mazhar, Khurram
    Elliott, Alan C.
    Rockey, Don C.
    GASTROENTEROLOGY, 2013, 144 (05) : S945 - S945
  • [4] The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites
    Aday, Ariel W.
    Mayo, Marlyn J.
    Elliott, Alan
    Rockey, Don C.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (02): : 169 - 176
  • [5] BETA-BLOCKERS IN THE MANAGEMENT OF PORTAL-HYPERTENSION
    BASS, NM
    CURRENT OPINION IN GASTROENTEROLOGY, 1988, 4 (03) : 438 - 443
  • [6] Clinical effects of beta-blockers on portal hypertension
    Kuga, K
    Onoda, Y
    Tanaka, S
    Komaba, M
    Kamoshita, H
    Toshima, K
    Uematu, M
    Imai, F
    Toda, G
    HEPATOLOGY, 1996, 23 (01) : P151 - P151
  • [7] BETA-BLOCKERS IN PORTAL-HYPERTENSION - AN OVERVIEW
    LEWIS, JA
    DAVIS, JM
    ALLSOPP, D
    CAMERON, HA
    DRUGS, 1989, 37 : 62 - 69
  • [8] Beta-blockers in portal hypertension: Unexpected limitations!
    Thevenot, Thierry
    Cervoni, Jean-Paul
    Di Martino, Vincent
    PRESSE MEDICALE, 2011, 40 (03): : 227 - 229
  • [9] Letter: nonselective beta-blockers, endoscopic therapy and portal vein thrombosis in cirrhosis
    Bosch, Jaume
    Berzigotti, Annalisa
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (10) : 1370 - 1371
  • [10] Examining the therapeutic landscape of beta-blockers in portal hypertension
    Brujats, Anna
    Villanueva, Candid
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)